129 related articles for article (PubMed ID: 19965664)
1. Rituximab inhibits B-cell receptor signaling.
Kheirallah S; Caron P; Gross E; Quillet-Mary A; Bertrand-Michel J; Fournié JJ; Laurent G; Bezombes C
Blood; 2010 Feb; 115(5):985-94. PubMed ID: 19965664
[TBL] [Abstract][Full Text] [Related]
2. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts.
Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D
J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721
[TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
4. Rituximab activates Syk and AKT in CD20-positive B cell lymphoma cells dependent on cell membrane cholesterol levels.
Nozaki Y; Mitsumori T; Yamamoto T; Kawashima I; Shobu Y; Hamanaka S; Nakajima K; Komatsu N; Kirito K
Exp Hematol; 2013 Aug; 41(8):687-696.e1. PubMed ID: 23603515
[TBL] [Abstract][Full Text] [Related]
5. Rapid desensitization of B-cell receptor by a dithiol-reactive protein tyrosine phosphatase inhibitor: uncoupling of membrane IgM from syk inhibits signals leading to Ca2+ mobilization.
Rozsnyay Z; Sarmay G; Gergely J
Immunol Lett; 1995 Jan; 44(2-3):149-56. PubMed ID: 7541023
[TBL] [Abstract][Full Text] [Related]
6. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.
Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K
Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777
[TBL] [Abstract][Full Text] [Related]
7. The autoinhibitory C-terminal SH2 domain of phospholipase C-γ2 stabilizes B cell receptor signalosome assembly.
Wang J; Sohn H; Sun G; Milner JD; Pierce SK
Sci Signal; 2014 Sep; 7(343):ra89. PubMed ID: 25227611
[TBL] [Abstract][Full Text] [Related]
8. FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas.
Szydlowski M; Kiliszek P; Sewastianik T; Jablonska E; Bialopiotrowicz E; Gorniak P; Polak A; Markowicz S; Nowak E; Grygorowicz MA; Prochorec-Sobieszek M; Szumera-Cieckiewicz A; Malenda A; Lech-Maranda E; Warzocha K; Juszczynski P
Blood; 2016 Feb; 127(6):739-48. PubMed ID: 26585955
[TBL] [Abstract][Full Text] [Related]
9. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1.
Maeda A; Scharenberg AM; Tsukada S; Bolen JB; Kinet JP; Kurosaki T
Oncogene; 1999 Apr; 18(14):2291-7. PubMed ID: 10327049
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.
Winiarska M; Bojarczuk K; Pyrzynska B; Bil J; Siernicka M; Dwojak M; Bobrowicz M; Miazek N; Zapala P; Zagozdzon A; Krol M; Syta A; Podszywalow-Bartnicka P; Pilch Z; Dabrowska-Iwanicka A; Juszczynski P; Efremov DG; Slabicki M; Zenz T; Le Roy A; Olive D; Rygiel TP; Leusen JH; Golab J
MAbs; 2014; 6(5):1300-13. PubMed ID: 25517315
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells.
Semac I; Palomba C; Kulangara K; Klages N; van Echten-Deckert G; Borisch B; Hoessli DC
Cancer Res; 2003 Jan; 63(2):534-40. PubMed ID: 12543813
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
13. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma.
Bogusz AM; Baxter RH; Currie T; Sinha P; Sohani AR; Kutok JL; Rodig SJ
Clin Cancer Res; 2012 Nov; 18(22):6122-35. PubMed ID: 22966017
[TBL] [Abstract][Full Text] [Related]
14. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
Juszczynski P; Chen L; O'Donnell E; Polo JM; Ranuncolo SM; Dalla-Favera R; Melnick A; Shipp MA
Blood; 2009 Dec; 114(26):5315-21. PubMed ID: 19855081
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival.
Wang YH; Fan L; Wang L; Zhang R; Zou ZJ; Fang C; Zhang LN; Li JY; Xu W
Leuk Lymphoma; 2013 Jun; 54(6):1165-70. PubMed ID: 23039362
[TBL] [Abstract][Full Text] [Related]
16. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
[TBL] [Abstract][Full Text] [Related]
17. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes.
Li HL; Davis WW; Whiteman EL; Birnbaum MJ; Puré E
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6890-5. PubMed ID: 10359809
[TBL] [Abstract][Full Text] [Related]
19. Low and nontoxic inorganic mercury burdens attenuate BCR-mediated signal transduction.
McCabe MJ; Laiosa MD; Li L; Menard SL; Mattingly RR; Rosenspire AJ
Toxicol Sci; 2007 Oct; 99(2):512-21. PubMed ID: 17656488
[TBL] [Abstract][Full Text] [Related]
20. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Sohn HW; Gu H; Pierce SK
J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
